These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30332941)

  • 1. Small Peptides as Modulators of Serine Proteases.
    Xu P; Huang M
    Curr Med Chem; 2020; 27(22):3686-3705. PubMed ID: 30332941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical review on marine serine protease and its inhibitors: A new wave of drugs?
    Barzkar N; Khan Z; Tamadoni Jahromi S; Pourmozaffar S; Gozari M; Nahavandi R
    Int J Biol Macromol; 2021 Feb; 170():674-687. PubMed ID: 33387547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A general strategy to inhibit serine protease by targeting its autolysis loop.
    Jiang L; Yuan C; Huang M
    FASEB J; 2021 Feb; 35(2):e21259. PubMed ID: 33417271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarylethene-Based Photoswitchable Inhibitors of Serine Proteases.
    Babii O; Afonin S; Diel C; Huhn M; Dommermuth J; Schober T; Koniev S; Hrebonkin A; Nesterov-Mueller A; Komarov IV; Ulrich AS
    Angew Chem Int Ed Engl; 2021 Sep; 60(40):21789-21794. PubMed ID: 34268844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural proteinaceous inhibitors of serine proteases.
    Debowski D
    Curr Pharm Des; 2013; 19(6):1068-84. PubMed ID: 23016680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.
    Xu P; Andreasen PA; Huang M
    Int J Biol Sci; 2017; 13(10):1222-1233. PubMed ID: 29104489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the serine proteases of the complement system.
    Gál P; Dobó J; Beinrohr L; Pál G; Závodszky P
    Adv Exp Med Biol; 2013; 735():23-40. PubMed ID: 23402017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ahp cyclodepsipeptides: the impact of the Ahp residue on the "canonical inhibition" of S1 serine proteases.
    Stolze SC; Meltzer M; Ehrmann M; Kaiser M
    Chembiochem; 2013 Jul; 14(11):1301-8. PubMed ID: 23794257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding serine proteases implications on Leishmania spp lifecycle.
    Alves CR; Souza RS; Charret KDS; Côrtes LMC; Sá-Silva MP; Barral-Veloso L; Oliveira LFG; da Silva FS
    Exp Parasitol; 2018 Jan; 184():67-81. PubMed ID: 29175018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitors to treat inflammation: a patent review (2011-2016).
    Soualmia F; El Amri C
    Expert Opin Ther Pat; 2018 Feb; 28(2):93-110. PubMed ID: 29171765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior.
    Almonte AG; Sweatt JD
    Brain Res; 2011 Aug; 1407():107-22. PubMed ID: 21782155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulated serine proteinase lytic system on mammalian sperm surface: there must be a role.
    Cesari A; Monclus Mde L; Tejón GP; Clementi M; Fornes MW
    Theriogenology; 2010 Sep; 74(5):699-711.e1-5. PubMed ID: 20537374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-Based Macrocyclic Inhibitors of Serine Proteases.
    Damalanka VC; Banas V; De Bona P; Kashipathy MM; Battaile K; Lovell S; Janetka JW
    J Med Chem; 2024 Mar; 67(6):4833-4854. PubMed ID: 38477709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.
    Antalis TM; Buzza MS; Hodge KM; Hooper JD; Netzel-Arnett S
    Biochem J; 2010 Jun; 428(3):325-46. PubMed ID: 20507279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protein scaffold, engineered SPINK2, for generation of inhibitors with high affinity and specificity against target proteases.
    Nishimiya D; Kawaguchi Y; Kodama S; Nasu H; Yano H; Yamaguchi A; Tamura M; Hashimoto R
    Sci Rep; 2019 Aug; 9(1):11436. PubMed ID: 31391482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial serine protease inhibitors and their therapeutic applications.
    Harish BS; Uppuluri KB
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1373-1387. PubMed ID: 28970170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition.
    Cercek L; Cercek B
    Cancer Detect Prev; 1993; 17(3):447-54. PubMed ID: 7691406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different serine protease inhibitors in validating the 115 kDa Leishmania donovani secretory serine protease as chemotherapeutic target.
    Chakraborti T; Das P; Choudhury R; De T
    Indian J Biochem Biophys; 2015 Feb; 52(1):14-22. PubMed ID: 26040107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lord of the Bacteria: The Fellowship of the Leader and Other Serine Protease Inhibitors.
    Burchacka E; Sieńczyk M
    Curr Pharm Des; 2018; 24(37):4445-4465. PubMed ID: 30569850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored Ahp-cyclodepsipeptides as Potent Non-covalent Serine Protease Inhibitors.
    Köcher S; Rey J; Bongard J; Tiaden AN; Meltzer M; Richards PJ; Ehrmann M; Kaiser M
    Angew Chem Int Ed Engl; 2017 Jul; 56(29):8555-8558. PubMed ID: 28514117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.